Accuray (ARAY) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.69% |
| Dec 31, 2025 | -33.24% |
| Sep 30, 2025 | -112.01% |
| Jun 30, 2025 | 19.39% |
| Mar 31, 2025 | -18.47% |
| Dec 31, 2024 | -24.21% |
| Sep 30, 2024 | 18.32% |
| Jun 30, 2024 | 34.90% |
| Mar 31, 2024 | -43.10% |
| Dec 31, 2023 | -14.87% |
| Sep 30, 2023 | 22.88% |
| Jun 30, 2023 | 52.05% |
| Mar 31, 2023 | 16.00% |
| Dec 31, 2022 | 19.73% |
| Sep 30, 2022 | 11.42% |
| Jun 30, 2022 | 23.14% |
| Mar 31, 2022 | 30.12% |
| Dec 31, 2021 | 15.07% |
| Sep 30, 2021 | 39.16% |
| Jun 30, 2021 | -5.92% |
| Mar 31, 2021 | -19.32% |
| Dec 31, 2020 | 21.29% |
| Sep 30, 2020 | 15.18% |
| Jun 30, 2020 | 18.33% |
| Mar 31, 2020 | 22.42% |
| Dec 31, 2019 | 23.93% |
| Sep 30, 2019 | 17.04% |
| Jun 30, 2019 | 31.23% |
| Mar 31, 2019 | 30.12% |
| Dec 31, 2018 | 6.51% |
| Sep 30, 2018 | 12.13% |
| Jun 30, 2018 | 47.47% |
| Mar 31, 2018 | 24.95% |
| Dec 31, 2017 | 31.57% |
| Sep 30, 2017 | 18.72% |
| Jun 30, 2017 | 26.52% |
| Mar 31, 2017 | 22.16% |
| Dec 31, 2016 | 6.01% |
| Sep 30, 2016 | 20.59% |
| Jun 30, 2016 | 25.79% |
| Mar 31, 2016 | 20.11% |
| Dec 31, 2015 | -25.74% |
| Sep 30, 2015 | -14.87% |